CIK 0001080014
- Large accelerated filer
Innoviva, Inc.
Sign in to watch- Ticker
- INVA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943265960
- Phone
- +1 650-238-9600
- Business address
- 1350 OLD BAYSHORE HIGHWAY, SUITE 400, BURLINGAME, CA, 94010
- Former names
- THERAVANCE INC, ADVANCED MEDICINE INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-08-15 | Winningham Rick E Director | Returned to the company | −96,250 | 825,391 | ||
| 2014-08-15 | Aguiar Michael W President & CEO | Grant or award | +43,905 | 288,840 | ||
| 2014-08-13 | LEE JUNNING Sr. VP, Technical Operations | Exercise or conversion | +13,882 | $9.81 | $136K | 258,324 |
| 2014-08-13 | LEE JUNNING Sr. VP, Technical Operations | Exercise or conversion | +12,516 | $14.53 | $182K | 270,840 |
| 2014-08-13 | LEE JUNNING Sr. VP, Technical Operations | Exercise or conversion | +24,338 | $12.66 | $308K | 295,178 |
| 2014-08-13 | LEE JUNNING Sr. VP, Technical Operations | Exercise or conversion | +23,705 | $12.66 | $300K | 318,883 |
| 2014-08-13 | LEE JUNNING Sr. VP, Technical Operations | Sale | −53,424 | $22.50 | $1.2M | 265,459 |
| 2014-08-13 | LEE JUNNING Sr. VP, Technical Operations | Exercise or conversion · Stock Option (Right to Buy) | −13,882 | 0 | ||
| 2014-08-13 | LEE JUNNING Sr. VP, Technical Operations | Exercise or conversion · Stock Option (Right to Buy) | −12,516 | 0 | ||
| 2014-08-13 | LEE JUNNING Sr. VP, Technical Operations | Exercise or conversion · Stock Option (Right to Buy) | −24,338 | 0 | ||
| 2014-08-13 | LEE JUNNING Sr. VP, Technical Operations | Exercise or conversion · Stock Option (Right to Buy) | −23,705 | 0 | ||
| 2014-08-12 | Shafer Bradford J Sr VP, Gen. Counsel, Secretary | Sale | −1,048 | $22.30 | $23K | 446,274 |
| 2014-08-11 | Shafer Bradford J Sr VP, Gen. Counsel, Secretary | Exercise or conversion | +33,667 | $14.53 | $489K | 474,430 |
| 2014-08-11 | Shafer Bradford J Sr VP, Gen. Counsel, Secretary | Sale | −27,108 | $22.12 | $600K | 447,322 |
| 2014-08-11 | Shafer Bradford J Sr VP, Gen. Counsel, Secretary | Exercise or conversion · Stock Option (Right to Buy) | +33,667 | $14.53 | $489K | 0 |
| 2014-08-11 | GLAXOSMITHKLINE PLC 10% owner | Purchase | +172,651 | $3,912,271.66 | $675.5B | 30,748,723 |
| 2014-07-24 | WITEK THEODORE L JR Sr. VP, Corp Partnerships | Grant or award · Stock Option Grant (Right to Buy) | +125,000 | 125,000 | ||
| 2014-06-19 | ABERCROMBIE GEORGE B Sr. VP, Corp. Partnerships | Grant or award | +10,000 | 10,000 | ||
| 2014-06-19 | ABERCROMBIE GEORGE B Sr. VP, Corp. Partnerships | Grant or award · Stock Option Grant (Right to Buy) | +100,000 | 100,000 | ||
| 2014-06-16 | Winningham Rick E Chief Executive Officer | Grant or award | +62,403 | 921,641 |
Page 18 of 23 · 446 trades